Profil
William H.
Collier currently works at Genevant Sciences Corp., as Director.
Mr. Collier also formerly worked at Arbutus Biopharma Corp., as President, Chief Executive Officer & Director from 2019 to 2023, Arbutus Biopharma, Inc., as President & Chief Executive Officer, International Partnership for Microbicides, as Director from 2018 to 2021, Glaxowellcom, as Area Director, Aids United, as Director from 2011 to 2018, and ViiV Healthcare Ltd., as President & GM-North America Region.
Mr. Collier received his undergraduate degree from the University of Manchester Institute of Science & Technology.
Aktive Positionen von William Collier
| Unternehmen | Position | Beginn |
|---|---|---|
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von William Collier
| Unternehmen | Position | Ende |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Vorstandsvorsitzender | 31.12.2023 |
Arbutus Biopharma, Inc.
Arbutus Biopharma, Inc. BiotechnologyHealth Technology Provides biotechnology and pharmaceutical solutions | Vorstandsvorsitzender | 31.12.2023 |
International Partnership for Microbicides
International Partnership for Microbicides BiotechnologyHealth Technology Develop human immunodeficiency virus prevention products | Direktor/Vorstandsmitglied | 01.01.2021 |
Aids United
Aids United Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for HIV epidemics | Direktor/Vorstandsmitglied | 01.01.2018 |
Glaxowellcom | Corporate Officer/Principal | - |
Ausbildung von William Collier
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
International Partnership for Microbicides
International Partnership for Microbicides BiotechnologyHealth Technology Develop human immunodeficiency virus prevention products | Health Technology |
Arbutus Biopharma Corp.
Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Arbutus Biopharma, Inc.
Arbutus Biopharma, Inc. BiotechnologyHealth Technology Provides biotechnology and pharmaceutical solutions | Health Technology |
University of Manchester Institute of Science & Technology
University of Manchester Institute of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Glaxowellcom | |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Aids United
Aids United Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for HIV epidemics | Commercial Services |
















